News & Events category:
Saint Mary's Hospital

A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.

An innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.

MFT, Research and Innovation colleagues mark 75 years of the National Health Service (NHS).

Manchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds.

University of Manchester Chancellor Nazir Afzal OBE has become the 1,000th person in Greater Manchester to take part in a huge research project.

Researchers tell an international conference that a new gene therapy for Sanfilippo disease – also known as childhood dementia – has shown promising early results in a proof-of-concept study.

A 20-month-old baby girl has become the first child in the UK to receive a life-saving gene therapy treatment for the fatal disorder, metachromatic leukodystrophy disease (MLD). 

A world-first genetic test to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic, has been conditionally recommended by NICE.